Ashley Addiction Treatment Partners With WHOOP on SUD Research Initiative
Ashley Addiction Treatment on Thursday announced a new research partnership with wearable fitness tech company Whoop to use its Unite platform to study substance use disorder recovery and relapse.
The research program will incorporate both data from WHOOP Unite and subjective patient feedback. Ashley will also become the first organization to use WHOOP Unite in conjunction with the recently launched WHOOP Gateway, which uses Bluetooth to retrieve biometric data—including heart rate, stress levels, and sleep patterns—from WHOOP’s wearable products and transmit it to Unite without a mobile phone.
“We are passionate about providing state-of-the-art care to every person who walks through our doors, which is why advancing the way we conduct research and invest in technology remains at the forefront of everything we do,” said Greg Hobelmann, MD, MPH, Ashley co-CEO and president, said in a news release.
“WHOOP Unite provides a holistic view of patients’ biometric data impacting their treatment, and WHOOP Gateway is the critical link to collecting a large dataset since our patients do not have access to mobile phones during treatment. The ability to gather this type of pivotal health information is a game-changer for our industry and Ashley’s one-of-its-kind database that’s enabling us to change the face of addiction medicine.”
The initiative with WHOOP aligns with ongoing research being conducted by Ashley and faculty from the Johns Hopkins University School of Medicine to better understand the causes of relapse and identify treatment protocols that reduce stress triggers and drive better treatment outcomes. Currently, about 60% of individuals relapse while in recovery, according to data from the National Institute on Drug Abuse.
“This research leveraging WHOOP Unite insights lays the groundwork for incorporating biometric assessments into routine care, and ultimately, creating a precision medicine model for addiction treatment,” Andrew Huhn, PhD, an associate professor at Johns Hopkins. Dr Huhn is overseeing an Internal Review Board study with patients at Ashley facilities.
Reference
